Lebrikizumab for Atopic Dermatitis: 4-Year Clearance, Itch Relief
Lebrikizumab sustained skin clearance and itch reduction in atopic dermatitis across four years of follow-up, per HCPLive's long-term extension coverage. Endpoint tables are not yet public.